Mike Matson
Stock Analyst at Needham
(3.13)
# 1,156
Out of 4,754 analysts
494
Total ratings
43.92%
Success rate
0.64%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Reiterates: Hold | n/a | $8.29 | - | 17 | Feb 27, 2025 | |
| ENOV Enovis | Maintains: Buy | $65 → $64 | $39.20 | +63.29% | 12 | Feb 27, 2025 | |
| MMSI Merit Medical Systems | Maintains: Buy | $122 → $116 | $104.65 | +10.85% | 24 | Feb 26, 2025 | |
| MASI Masimo | Reiterates: Hold | n/a | $192.57 | - | 24 | Feb 26, 2025 | |
| LIVN LivaNova | Maintains: Buy | $75 → $64 | $41.98 | +52.45% | 24 | Feb 26, 2025 | |
| AORT Artivion | Maintains: Buy | $34 → $32 | $25.73 | +24.37% | 16 | Feb 25, 2025 | |
| VCYT Veracyte | Reiterates: Buy | $51 | $34.21 | +49.10% | 16 | Feb 25, 2025 | |
| PEN Penumbra | Reiterates: Hold | n/a | $286.06 | - | 10 | Feb 19, 2025 | |
| MDT Medtronic | Reiterates: Hold | n/a | $94.42 | - | 17 | Feb 19, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $19 → $18 | $9.84 | +82.93% | 24 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $38.85 | +31.27% | 31 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $106.66 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $112 → $108 | $66.59 | +62.20% | 11 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $63.70 | - | 19 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $91 | $59.74 | +52.33% | 23 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $104.69 | - | 26 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $72.05 | - | 7 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $19.32 | - | 16 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $235.32 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $31.22 | - | 20 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $13 | $13.02 | -0.12% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $442 | $395.05 | +11.88% | 7 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $23.50 | +78.72% | 20 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7.25 | $4.01 | +81.02% | 18 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $136.22 | - | 8 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.5 | $1.43 | +74.83% | 16 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4.25 | $2.79 | +52.34% | 15 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $150.55 | - | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $222.51 | - | 10 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $17.83 | +135.56% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $80.61 | -6.96% | 1 | Feb 18, 2021 |
Inogen
Feb 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.29
Upside: -
Enovis
Feb 27, 2025
Maintains: Buy
Price Target: $65 → $64
Current: $39.20
Upside: +63.29%
Merit Medical Systems
Feb 26, 2025
Maintains: Buy
Price Target: $122 → $116
Current: $104.65
Upside: +10.85%
Masimo
Feb 26, 2025
Reiterates: Hold
Price Target: n/a
Current: $192.57
Upside: -
LivaNova
Feb 26, 2025
Maintains: Buy
Price Target: $75 → $64
Current: $41.98
Upside: +52.45%
Artivion
Feb 25, 2025
Maintains: Buy
Price Target: $34 → $32
Current: $25.73
Upside: +24.37%
Veracyte
Feb 25, 2025
Reiterates: Buy
Price Target: $51
Current: $34.21
Upside: +49.10%
Penumbra
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $286.06
Upside: -
Medtronic
Feb 19, 2025
Reiterates: Hold
Price Target: n/a
Current: $94.42
Upside: -
NeoGenomics
Feb 19, 2025
Maintains: Buy
Price Target: $19 → $18
Current: $9.84
Upside: +82.93%
Feb 13, 2025
Reiterates: Buy
Price Target: $51
Current: $38.85
Upside: +31.27%
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $106.66
Upside: -
Feb 7, 2025
Maintains: Buy
Price Target: $112 → $108
Current: $66.59
Upside: +62.20%
Feb 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $63.70
Upside: -
Feb 6, 2025
Maintains: Buy
Price Target: $97 → $91
Current: $59.74
Upside: +52.33%
Feb 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $104.69
Upside: -
Feb 5, 2025
Reiterates: Hold
Price Target: n/a
Current: $72.05
Upside: -
Feb 4, 2025
Maintains: Hold
Price Target: n/a
Current: $19.32
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $235.32
Upside: -
Jan 30, 2025
Reiterates: Hold
Price Target: n/a
Current: $31.22
Upside: -
Jan 29, 2025
Downgrades: Hold
Price Target: $13
Current: $13.02
Upside: -0.12%
Jan 29, 2025
Reiterates: Buy
Price Target: $442
Current: $395.05
Upside: +11.88%
Jan 14, 2025
Reiterates: Buy
Price Target: $42
Current: $23.50
Upside: +78.72%
Jan 8, 2025
Maintains: Buy
Price Target: $7.25
Current: $4.01
Upside: +81.02%
Dec 16, 2024
Reiterates: Hold
Price Target: n/a
Current: $136.22
Upside: -
Nov 14, 2024
Reiterates: Buy
Price Target: $2.5
Current: $1.43
Upside: +74.83%
Nov 13, 2024
Reiterates: Buy
Price Target: $4.25
Current: $2.79
Upside: +52.34%
Nov 13, 2024
Reiterates: Hold
Price Target: n/a
Current: $150.55
Upside: -
Nov 8, 2024
Reiterates: Hold
Price Target: n/a
Current: $222.51
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $17.83
Upside: +135.56%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $80.61
Upside: -6.96%